Assidicky R, Tokat UM, Tarman IO, Saatci O, Ersan PG, Raza U et al (2022) Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer. J Breast cancer Res 193(2):331–348

Article  CAS  Google Scholar 

Cheng C-W, Liu Y-F, Yu J-C, Wang H-W, Ding S-L, Hsiung C-N et al (2012) Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast. J Annals Surg Oncol 19:4129–4139

Article  Google Scholar 

da Silva JL, Rodrigues FR, de Mesquita GG, Fernandes PV, Thuler LCS, de Melo AC et al (2021) Triple-negative breast cancer: assessing the role of immunohistochemical biomarkers on neoadjuvant treatment. J Breast Cancer: Targets 31–44

Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA et al (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. J Clin cancer Res 13(15):4429–4434

Article  Google Scholar 

Geyer FC, Pareja F, Weigelt B, Rakha E, Ellis IO, Schnitt SJ et al (2017) The spectrum of triple-negative breast disease: high-and low-grade lesions. J Am J Pathol 187(10):2139–2151

Article  CAS  PubMed  Google Scholar 

Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A et al (2020) Visualizing and interpreting cancer genomics data via the Xena platform. 38(6):675–678

Goto Y, Thike AA, Ong CCH, Lim JX, Nasir NDM, Li H et al (2020) Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer. J J Clin Pathol 73(3):147–153

Article  CAS  PubMed  Google Scholar 

Hannafon BN, Gin AL, Xu Y-F, Bruns M, Calloway CL, Ding W-Q (2019) Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells. J Cell Communication Signal 17(1):1–13

Google Scholar 

Jang KS, Paik SS, Chung H, Oh YH, Kong G (2006) MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. J Cancer Sci 97(5):374–379

Article  CAS  Google Scholar 

Kulkarni A, Kelkar DA, Parikh N, Shashidhara LS, Koppiker CB, Kulkarni M (2020) Meta-analysis of prevalence of triple-negative breast cancer and its clinical features at incidence in Indian patients with breast cancer. J JCO Global Oncol 6:1052–1062

Article  Google Scholar 

Kumar S, Bal A, Das A, Bhattacharyya S, Laroiya I, Khare S et al (2021) Molecular subtyping of triple negative breast cancer by surrogate immunohistochemistry markers. J Appl Immunohistochem Mol Morphology 29(4):251–257

Article  CAS  Google Scholar 

Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA et al (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J J Clin Oncol 26(8):1275–1281

Article  PubMed  Google Scholar 

Mitri ZI, Abuhadra N, Goodyear SM, Hobbs EA, Kaempf A, Thompson AM et al (2022) Impact of TP53 mutations in Triple negative breast Cancer. J NPJ Precision Oncol 6(1):64

Article  CAS  Google Scholar 

Skinner KE, Haiderali A, Huang M, Schwartzberg LS (2021) Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer. J Future Oncol 17(8):931–941

Article  CAS  Google Scholar 

Sporikova Z, Koudelakova V, Trojanec R, Hajduch M (2018) Genetic markers in triple-negative breast cancer. J Clin Breast cancer 18(5):e841–e50

Article  CAS  Google Scholar 

Srivastava A (2017) Mammographic screening or breast cancer awareness? Time to ponder. J Indian J Surg 79(5):446–449

Article  PubMed  Google Scholar 

Stewart RL, Updike KL, Factor RE, Henry NL, Boucher KM, Bernard PS et al (2019) A multigene assay determines risk of recurrence in patients with triple-negative breast cancer. J Cancer Res 79(13):3466–3478

Article  CAS  Google Scholar 

Thakur KK, Bordoloi D, Kunnumakkara AB (2018) Alarming burden of triple-negative breast cancer in India. J Clin Breast cancer 18(3):e393–e9

Article  Google Scholar 

Thike AA, Iqbal J, Cheok PY, Chong APY, Tse GM-K, Tan B et al (2010) Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. J Am J Surg Pathol 34(7):956–964

Article  PubMed  Google Scholar 

Tseng L, Hsu N, Chen S, Lu Y, Lin C, Chang D et al (2013) Distant metastasis in triple-negative breast cancer. J Neoplasma 60(3):290–294

Article  CAS  Google Scholar 

Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke E-M et al (2019) A phase II study of talazoparib after platinum or cytotoxic nonplatinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations (ABRAZO). J Clin Cancer Res 25(9):2717–2724

Article  CAS  Google Scholar 

Untch M, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe H-H et al (2015) Primary therapy of patients with early breast cancer: evidence, controversies, consensus. 75(06):556–565

Wu M, Wen L, Zhou Y, Wu W (2022) Role of lncRNA AGAP2-AS1 in breast cancer cell resistance to apoptosis by the regulation of MTA1 promoter activity. J Technol cancer Res Treat 21:15330338221085361

CAS  Google Scholar 

Zhang S-B, Tang Q-R (2016) Predicting protein subcellular localization based on information content of gene ontology terms. J Comput Biology Chem 65:1–7

Article  Google Scholar